Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Lung Center of the Philippines

Status

Completed

Conditions

COVID-19

Lung TB

Hemoptysis

Lung Cancer

Treatments

Procedure: anatomic lung resection

Study type

Observational

Funder types

Other

Identifiers

NCT05513248

LCP-SF-013-2022

Details and patient eligibility

About

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.

Full description

This study will be conducted at the Lung Center of the Philippines. The study design is a retrospective case series implemented via chart review. Online and written patient records will be reviewed to determine the baseline patient characteristics and the preoperative outcomes. Patients who recovered from COVID-19 will be selected from those who underwent anatomic lung resection from June 1, 2020 to May 31, 2022. This study will be done in accordance with the Helsinky Declaration and Good Clinical Practice Guidelines, and will be subject for approval of the institutional Ethics and Technical Review Boards. Descriptive statistics will be used to describe patient characteristics and perioperative outcomes.

Enrollment

16 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

underwent anatomic lung resection
previous COVID-19 infection documented by nasopharyngeal swab RT-PCR or GeneXpert
with negative nasopharyngeal swab RT-PCR or GeneXpert prior to lung resection

Exclusion criteria